Planchat Arnaud, Robert-Ebadi Helia, Saudan Patrick, Jaques David
Service de cardiologie, Département de médecine, Hôpitaux universitaires de Genève, 1211 Genève 14.
Service d'angiologie et d'hémostase, Département de médecine, Hôpitaux universitaires de Genève, 1211 Genève 14.
Rev Med Suisse. 2022 Mar 2;18(771):390-393. doi: 10.53738/REVMED.2022.18.771.390.
Arteriovenous fistula (AVF) remains the vascular access of choice in hemodialysis but generates cardiovascular constraints. Its creation immediately induces an increase in cardiac output. Increased venous return and subsequent volume overload lead to biventricular remodeling, and eventually to dysfunction. High-output heart failure (HOHF) caused by high-flow AVF is a recognized but not strictly defined clinical entity, based on the combination of hypervolemia with an elevated cardiac output. A Qa greater than 2 L/min is a risk factor for HOHF, particularly in susceptible patients. The most used flow reduction procedure is post-anastomotic vein caliber reduction by a banding technique, relieving symptoms and partially reversing previously induced structural abnormalities, but the benefit often remains limited in time.
动静脉内瘘(AVF)仍是血液透析中首选的血管通路,但会带来心血管方面的限制。其建立会立即导致心输出量增加。静脉回流增加及随后的容量超负荷会导致双心室重塑,最终引发功能障碍。高流量AVF所致的高输出量心力衰竭(HOHF)是一种已被认识但未严格定义的临床病症,基于血容量过多与心输出量升高的组合。Qa大于2 L/分钟是HOHF的一个危险因素,尤其是在易感患者中。最常用的流量减少方法是通过绑扎技术减小吻合口后静脉管径,缓解症状并部分逆转先前诱发的结构异常,但这种益处通常在时间上较为有限。